Study Stopped
no Inclusion
A New Way to Detect Acute Kidney Injury
VEX-CARDS
no Inclusion
VEX-CARDS
Sponsor study identifier
Secondary identifiers
OTHER · ANSM
observational
0
1 country
1
Study Start
October 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
October 1, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
April 1, 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Acute renal failure after cardiac surgery is a common postoperative complication, affecting approximately 20% of patients. It is associated with an increase in short-term mortality and an increase in hospital stay; but is also associated with an increase in long-term mortality of up to 30% at 5 years, even if renal function recovers upon discharge. Its origin is multifactorial: intraoperative hypoperfusion, including hemodynamic variations related to extracorporeal circulation or bleeding, postoperative hypoperfusion related to cardiogenic or vasoplegic shock, ischemia-reperfusion phenomena leading to cell lysis or inflammation at the tubular level, inflammation and oxidative stress related to extracorporeal circulation, and hemolysis are the main causes. Hydro-sodium overload and associated venous congestion is also one of the etiologies of acute renal failure in post-operative cardiac surgery and is associated with increased mortality. The proposed pathophysiological mechanism is based on the decrease in renal tissue perfusion pressure due to the increase in venous pressure. In the extreme, the increase in pressure in the renal capsule could lead to true renal ischemia due to engorgement. This renal congestion can be diagnosed based on clinical signs, biological signs (such as NT-pro-BNP) or by monitoring by central venous pressure (CVP). However, these statistical tools have low diagnostic performance, and new tools based on ultrasound and Doppler are being developed. Indeed, alterations in venous flow in the renal, suprahepatic and portal veins, reflecting the increase in pressures there, are associated with the onset of acute renal failure in post-operative cardiac surgery.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 1, 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 22, 2025
Actual (reported)September 30, 2025
Actual (reported)October 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
October 1, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
April 1, 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
To study the association between the VEXUS score and the occurrence of acute renal failure post-operatively after cardiac surgery.
Onset of acute renal failure characterized by a score greater than or equal to KDIGO 1. (KDIGO 1 : Creatinine increased by \>26.5 µmol/L or 1.5-1.9 times the reference value, Diuresis \<0.5 mL/kg/h for 6-12 hours; KDIGO 2 : Creatinine x 2-2.9 compared to the reference value, Diuresis \< 0.5/mL/kg/h for \> 12h; KDIGO 3 : Creatinine x 3 or increase of \>353.6 µmol/L compared to the reference value Use of extra-renal replacement therapy, Diuresis \< 0.3 mL/kg/h for \> 24 hours or anuria for \> 12 hours.)
visit Hour no. 02, i.e. 2 hours after the intervention; visit Day 1 and visit Day 2
Study of the correlation or association between the VEXUS score and - the value of Central Venous Pressure (CVP)
visit Hour no. 02, i.e. 2 hours after the intervention; visit Day 1 and visit Day 2
Study of the correlation or association between the VEXUS score and the NT-pro-BNP level
visit Hour no. 02, i.e. 2 hours after the intervention; visit Day 1 and visit Day 2
Study of the correlation or association between the VEXUS score and the Hydro-sodium balance in intensive care
visit Hour no. 02, i.e. 2 hours after the intervention; visit Day 1 and visit Day 2
Study of the correlation or association between the VEXUS score and The time of the first dose of diuretics administered
visit Hour no. 02, i.e. 2 hours after the intervention; visit Day 1 and visit Day 2
Study of the correlation or association between the VEXUS score and The onset of chronic renal failure (assessed at 3 months)
visit month 3
The aim is to prospectively evaluate the association between the ultrasound score (VEXUS) and the occurrence of acute renal failure post-operatively following cardiac surgery. The VEXUS (Venous Excess UltraSound) score is an ultrasound tool used in medicine to assess systemic venous congestion, i.e. excess pressure in the venous system linked to volume overload or right heart failure. The VEXUS score relies on ultrasound of the inferior vena cava (IVC) to assess the extent of congestion in this vein. score 0 : Normal IVC + Normal Dopplers; score 1 : Dilated IVC + altered hepatic venous Doppler, but normal portal vein; score 2 : Portal vein shows significant pulsatility; score 3 : Severe pulsatility + marked alteration of hepatic and portal flow
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Adult patient undergoing valve surgery and/or bypass surgery under extracorporeal circulation (ECC).
University Rouen Hospital
Rouen, 76031, France
As part of routine intensive care, blood samples are taken daily to measure creatinine, blood ionogram, NT-pro-BNP, and troponin levels. The results of these measurements will be analyzed as part of the study
0 participants (actual enrollment reported by the registry).
First Submitted
September 22, 2025
First Posted
September 30, 2025
Study Start
October 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study of Kidney Circulating Cell-free DNA in Patients With Acute Kidney Failure
Contact the study team to confirm eligibility.
Primary Completion
October 1, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
April 1, 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
June 2, 2026
Record last verified: 2025-09
The data provided will be the property of the sponsor and will be used solely for its own research activities.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: